Europe
Bactiguard’s indwelling urinary catheters are now approved for reimbursement in the Netherlands, which means that healthcare providers in the home care market can provide patients with Bactiguard’s products for infection prevention and improve their quality of life.
Pratteln, Switzerland, September 10, 2019 – Santhera Pharmaceuticals announces the online publication of Phase I data with its human neutrophil elastase inhibitor POL6014 in the Journal of Cystic Fibrosis.
Novartis Chief Executive Officer Vas Narasimhan has pledged the company will be more forthcoming with the U.S. Food and Drug Administration and other regulatory agencies regarding data mismanagement and manipulations in the future.
‘iM-TCRs’ enable controllable cytotoxicity of tumor-specific TCR-T cells to potentially tune safety and efficacy according to clinical needs
EuroFanColen researchers published in Nature Medicine first clinical results for Fanconi anemia patients
New role builds on growing interest in BioAscent’s integrated discovery services
PharmaMar (MSE:PHM) presented new data on lurbinectedin during the World Conference on Lung Cancer (WCLC), which is taking place from 7th to 10th September in Barcelona.
Sphere Fluidics introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell line development.
Lightcast Discovery Ltd announces that it has raised £1.3 m in seed financing from private investors to develop the capabilities and applications of its platform including continuing to expand its range of pilot studies.
With more than 25 years experience in chemotherapeutic products and cancer vaccines, she will lead the ongoing phase I/II trial in NSCLC
PRESS RELEASES